Characteristics of Endoret®(prgf®) technology
- It is simple as it requires just one centrifugation On the other hand, other technologies use several centrifugations, which can cause the nonspecific activation of platelets..
- The volume of blood used is variable (from 9ml) and adequate for each application. Endoret®(prgf®) technology is the most efficient technology in the market to obtain plasma..
- It is precise because it allows you to control the moment the plasma is activated..
- It uses concentrations of growth factors within the therapeutic window for the stimulation of tissue regeneration as has been demonstrated in in-vitro research, in animals or in clinical trials. Other products use concentrations outside this window, obtaining unpredictable results.
- 100% biocompatible, safe and versatile
- It does not include leucocytes in its formulation, thus avoiding their proinflammatory effects.
Intended for international use only. Indications for use of products and/or therapies contained herein may not be cleared /approved for use by the following Health international agencies: US Food & Drug Administration, Health Canada or Japanese Health Ministry. To access the specific information of your market, use the country selector located on the top menu of this page.